Suppr超能文献

与倍他洛尔相关的具有α和β肾上腺素能活性的衍生物。

Derivatives related to betaxolol with alpha- and beta-adrenergic activities.

作者信息

Leclerc G, Decker N, Schwartz J

出版信息

Arzneimittelforschung. 1985;35(9):1357-67.

PMID:2867769
Abstract

The paper describes the synthesis and the pharmacological evaluation of some derivatives of betaxolol, all with a N-aralkylamine instead of the tertiobutylamine. Their general formulas are: (Formula: see text). These compounds have been tested for beta 1-adrenergic receptors antagonism on guinea pig atria, beta 2-adrenergic receptor antagonism on guinea pig trachea and alpha-adrenergic blocking activity on rat aorta. Compound U12 with a marked alpha-blocking activity and compound R8 with a beta 1/alpha ratio = 1 were selected for a haemodynamic study in the dog. The decrease in cardiac work and the diminution of total peripheral resistance exhibited by U12 are consistent with a dual alpha/beta-blocking agent. Finally, structure-activity relationships are discussed.

摘要

本文描述了一些倍他洛尔衍生物的合成及药理学评价,所有衍生物均含有N-芳烷基胺而非叔丁胺。它们的通式为:(通式:见原文)。这些化合物已在豚鼠心房上测试了β1-肾上腺素能受体拮抗作用,在豚鼠气管上测试了β2-肾上腺素能受体拮抗作用,并在大鼠主动脉上测试了α-肾上腺素能阻断活性。选择具有显著α-阻断活性的化合物U12和β1/α比值 = 1的化合物R8进行犬的血流动力学研究。U12表现出的心脏功降低和总外周阻力减小与双重α/β阻断剂一致。最后,讨论了构效关系。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验